[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_8453 

# __Drug-resistant tuberculosis requiring prolonged and challenging treatment__

## Articles mentionning the risk

* [Escombe_upper-room_2009](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_464.md)

## Mitigations of this risk

* [Strict adherence to treatment guidelines, use of multiple second-line antibiotics](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_10343.md)

## Name of the risk

Difficulty in curing tuberculosis and increased risk of further drug resistance

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Individuals with drug-resistant tuberculosis](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6990.md)

## Stakeholders who can mitigate this risk

* [Healthcare facilities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_0.md)
* [Public health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_33.md)

## Technologies linked to the risk

* [Drug susceptibility testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_10159.md)
* [Second-line antibiotics](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_10160.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Failure to implement preventive measures](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_12.md)

